Marvel Biosciences Corp Stock Today
| MRVL Stock | 0.17 0.01 6.25% |
Performance7 of 100
| Odds Of DistressOver 58
|
Marvel Biosciences is selling for under 0.17 as of the 22nd of November 2024; that is 6.25% increase since the beginning of the trading day. The stock's lowest day price was 0.16. Marvel Biosciences has over 58 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Marvel Biosciences Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Marvel Biosciences is entity of Canada. It is traded as Stock on V exchange. The company has 44.79 M outstanding shares of which 267 shares are now shorted by private and institutional investors with about 0.02 days to cover all short positions. More on Marvel Biosciences Corp
Moving against Marvel Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Marvel Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Marvel Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Marvel Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive CEO | Roderick Matheson | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Marvel Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Marvel Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMarvel Biosciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Marvel Biosciences' financial leverage. It provides some insight into what part of Marvel Biosciences' total assets is financed by creditors.
| |||||
Marvel Biosciences Corp (MRVL) is traded on TSX Venture Exchange in Canada and employs 4 people. Marvel Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Marvel Biosciences's market, we take the total number of its shares issued and multiply it by Marvel Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Marvel Biosciences Corp operates under Biotechnology sector and is part of Health Care industry. The entity has 44.79 M outstanding shares of which 267 shares are now shorted by private and institutional investors with about 0.02 days to cover all short positions.
Marvel Biosciences generates negative cash flow from operations
Check Marvel Biosciences Probability Of Bankruptcy
Ownership AllocationMarvel Biosciences Corp maintains a total of 44.79 Million outstanding shares. Marvel Biosciences Corp holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Marvel Ownership Details
Marvel Biosciences Corp Risk Profiles
Although Marvel Biosciences' alpha and beta are two of the key measurements used to evaluate Marvel Biosciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.03 | |||
| Semi Deviation | 5.93 | |||
| Standard Deviation | 7.71 | |||
| Variance | 59.38 |
Marvel Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Marvel Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.